North America and Europe


New technology prevents vaccine freeze damage

PATH scientists have developed a formulation method that protects critical childhood vaccines from freezing, thus solving a longstanding public health problem. To help safeguard these lifesaving vaccines, PATH placed the technology in the public domain and transferred it to three commercial vaccine producers.

Learn more:

More than 1,500 people support global health by making a gift to PATH

Support from individuals is critical to PATH’s work, helping us turn innovative ideas into workable solutions for people in poor countries—and inspiring others to take action. In 2009, thousands of people took action for global health by making a gift to PATH, joining us online, or simply spreading the word.

Learn more:

Washington, DC

Global Health Technologies Coalition launches

The Global Health Technologies Coalition brings more than 30 organizations together to advocate for the development of new health tools.

Learn more:


Vaccine partners team up against bacterial causes of diarrhea

We are working to develop vaccines against Shigella and enterotoxigenic Escherichia coli (ETEC), which together kill more than one million people each year.

Learn more:


Team develops new tool to help countries address multidrug-resistant tuberculosis

PATH is working in Ukraine, Tanzania, and India to help countries and partners assess national tuberculosis (TB) programs and identify strengths and gaps related to preventing, diagnosing, and treating multidrug-resistant TB.

Learn more:

Map of North America, including cities where PATH has offices.

Map of Europe.

PATH’s US locations include our Seattle, Washington, headquarters and offices in Bethesda, Maryland, and Washington, DC. In Europe, we operate offices in Belgium, France, and Ukraine.

More about our offices »